25 September 2017 - With prescription drug prices continuing to strain state budgets, the National Governors Association is planning a meeting later this year to explore strategies for lowering costs, notably for hepatitis C drugs. 

And payers and drug makers will be invited, according to one state official familiar with the plan.

Details have not been disclosed, but the effort reflects ongoing concern that some medicines remain out of reach for people who rely on cash-strapped state Medicaid programs, according to Dr. Rebekah Gee, the Louisiana Department of Health secretary, who has been involved in the planning.

Read Stat News article